CMRX insider transaction filings
CHIMERIX INC — 49 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-04-21. Screen CMRX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CMRX between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — CHIMERIX INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-21 | 4 | Vakiener Victoria — Director | Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) | EDGAR |
| 2025-04-21 | 4 | Sherman Michael A. — Chief Executive Officer, Director | Disposition to issuer (D): 87,000 @ $8.55 · Disposition to issuer (D): 102,995 @ $8.55 · Disposition to issuer (D): 233,413 @ $8.55 · Disposition to issuer (D): 1,150,000 (derivative) · Disposition to issuer (D): 632,500 (derivative) · Disposition to issuer (D): 700,000 (derivative) · +3 more | EDGAR |
| 2025-04-21 | 4 | Riga Thomas J — COO and CCO | Disposition to issuer (D): 60,828 @ $8.55 · Disposition to issuer (D): 800,000 (derivative) · Disposition to issuer (D): 325,000 (derivative) | EDGAR |
| 2025-04-21 | 4 | Multani Pratik S — Director | Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) | EDGAR |
| 2025-04-21 | 4 | MIDDLETON FRED A — Director | Disposition to issuer (D): 40,000 @ $8.55 · Disposition to issuer (D): 60,000 @ $8.55 · Disposition to issuer (D): 2,776,093 @ $8.55 · Disposition to issuer (D): 531,861 @ $8.55 · Disposition to issuer (D): 207,523 @ $8.55 · Disposition to issuer (D): 42,000 (derivative) · +7 more | EDGAR |
| 2025-04-21 | 4 | Meyer Robert J. — Director | Disposition to issuer (D): 35,150 @ $8.55 · Disposition to issuer (D): 42,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · +3 more | EDGAR |
| 2025-04-21 | 4 | Melemed Allen S. — CHIEF MEDICAL OFFICER | Disposition to issuer (D): 173,852 @ $8.55 · Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 190,000 (derivative) · Disposition to issuer (D): 240,000 (derivative) · Disposition to issuer (D): 154,260 (derivative) · Disposition to issuer (D): 168,750 (derivative) · +1 more | EDGAR |
| 2025-04-21 | 4 | LaSpaluto Michelle — CHIEF FINANCIAL OFFICER | Disposition to issuer (D): 181,541 @ $8.55 · Disposition to issuer (D): 18,700 (derivative) · Disposition to issuer (D): 1,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 13,000 (derivative) · +9 more | EDGAR |
| 2025-04-21 | 4 | KOZIN MARC D — Director | Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) | EDGAR |
| 2025-04-21 | 4 | Jakeman David — VP OF FINANCE AND ACCOUNTING | Disposition to issuer (D): 156,209 @ $8.55 · Disposition to issuer (D): 10,150 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 7,200 (derivative) · Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 9,360 (derivative) · +10 more | EDGAR |
| 2025-04-21 | 4 | DEMSKI MARTHA J — Director | Disposition to issuer (D): 72,055 @ $8.55 · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · Disposition to issuer (D): 21,000 (derivative) · +5 more | EDGAR |
| 2025-04-21 | 4 | Decker Lisa Lynn — Director | Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) | EDGAR |
| 2025-04-21 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Disposition to issuer (D): 630,828 @ $8.55 · Disposition to issuer (D): 450,000 (derivative) · Disposition to issuer (D): 192,500 (derivative) · Disposition to issuer (D): 250,000 (derivative) · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 192,825 (derivative) · +3 more | EDGAR |
| 2025-04-21 | 4 | Alrutz Michael Albert — SVP AND GENERAL COUNSEL | Disposition to issuer (D): 216,689 @ $8.55 · Disposition to issuer (D): 178,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 45,750 (derivative) · Disposition to issuer (D): 135,000 (derivative) · Disposition to issuer (D): 176,000 (derivative) · +6 more | EDGAR |
| 2025-02-14 | 4 | Melemed Allen S. — CHIEF MEDICAL OFFICER | Sale (S): 3,065 @ $4.50 | EDGAR |
| 2025-02-14 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Sale (S): 7,370 @ $4.52 | EDGAR |
| 2025-02-14 | 4 | Alrutz Michael Albert — SVP AND GENERAL COUNSEL | Sale (S): 1,600 @ $4.52 | EDGAR |
| 2025-02-14 | 4 | Jakeman David — VP OF FINANCE AND ACCOUNTING | Sale (S): 300 @ $4.53 | EDGAR |
| 2025-02-14 | 4 | LaSpaluto Michelle — CHIEF FINANCIAL OFFICER | Sale (S): 2,260 @ $4.51 | EDGAR |
| 2025-01-31 | 4 | Jakeman David — VP OF FINANCE AND ACCOUNTING | Sale (S): 2,800 @ $4.10 | EDGAR |
| 2025-01-31 | 4 | LaSpaluto Michelle — CHIEF FINANCIAL OFFICER | Sale (S): 1,015 @ $4.11 | EDGAR |
| 2025-01-31 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Sale (S): 2,350 @ $4.10 | EDGAR |
| 2025-01-10 | 4 | LaSpaluto Michelle — CHIEF FINANCIAL OFFICER | Grant/award (A): 41,667 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Melemed Allen S. — CHIEF MEDICAL OFFICER | Grant/award (A): 45,925 @ $0 · Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Jakeman David — VP OF FINANCE AND ACCOUNTING | Grant/award (A): 10,855 @ $0 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Riga Thomas J — COO and CCO | Grant/award (A): 54,275 @ $0 · Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Alrutz Michael Albert — SVP AND GENERAL COUNSEL | Grant/award (A): 41,667 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Grant/award (A): 150,000 @ $0 · Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2024-10-30 | 4 | MIDDLETON FRED A — Director | Gift (G): 60,000 @ $0 | EDGAR |
| 2024-08-09 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Sale (S): 1,285 @ $0.83 | EDGAR |
| 2024-06-21 | 4 | Vakiener Victoria — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Multani Pratik S — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | MIDDLETON FRED A — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Meyer Robert J. — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | KOZIN MARC D — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Decker Lisa Lynn — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | DEMSKI MARTHA J — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Sherman Michael A. — Chief Executive Officer, Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-03-21 | 4 | KOZIN MARC D — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Sale (S): 1,744 @ $1.04 | EDGAR |
| 2024-02-16 | 4 | LaSpaluto Michelle — CHIEF FINANCIAL OFFICER | Sale (S): 1,940 @ $1.04 | EDGAR |
| 2024-02-16 | 4 | Jakeman David — VP OF FINANCE AND ACCOUNTING | Sale (S): 2,660 @ $1.04 | EDGAR |
| 2024-02-02 | 4 | Alrutz Michael Albert — SVP AND GENERAL COUNSEL | Grant/award (A): 21,875 @ $0 · Grant/award (A): 131,250 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Melemed Allen S. — CHIEF MEDICAL OFFICER | Grant/award (A): 28,125 @ $0 · Grant/award (A): 168,750 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Jakeman David — VP OF FINANCE AND ACCOUNTING | Grant/award (A): 10,750 @ $0 · Grant/award (A): 64,500 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Andriole Michael T. — PRESIDENT AND CEO, Director | Grant/award (A): 83,750 @ $0 · Grant/award (A): 502,500 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | LaSpaluto Michelle — CHIEF FINANCIAL OFFICER | Grant/award (A): 25,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-01-02 | 4 | Decker Lisa Lynn — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-12-29 | 4 | Andriole Michael T. — President and CEO, Director | Gift (G): 17,000 @ $0 | EDGAR |
Recent 8-K events — CHIMERIX INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-04-21 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-05 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-03 | 8-K | 8.01 — Other Events | EDGAR |
| 2024-12-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events | EDGAR |
| 2024-12-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CMRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →